U.S. markets close in 6 hours 20 minutes
  • S&P 500

    4,440.28
    -15.20 (-0.34%)
     
  • Dow 30

    34,955.51
    +157.51 (+0.45%)
     
  • Nasdaq

    14,880.76
    -166.94 (-1.11%)
     
  • Russell 2000

    2,248.07
    -10.97 (-0.49%)
     
  • Crude Oil

    75.50
    +1.52 (+2.05%)
     
  • Gold

    1,752.50
    +0.80 (+0.05%)
     
  • Silver

    22.65
    +0.22 (+0.98%)
     
  • EUR/USD

    1.1699
    -0.0019 (-0.16%)
     
  • 10-Yr Bond

    1.4890
    +0.0290 (+1.99%)
     
  • GBP/USD

    1.3695
    +0.0015 (+0.11%)
     
  • USD/JPY

    110.9440
    +0.2590 (+0.23%)
     
  • BTC-USD

    43,430.70
    +198.45 (+0.46%)
     
  • CMC Crypto 200

    1,081.95
    -19.57 (-1.78%)
     
  • FTSE 100

    7,050.66
    -0.82 (-0.01%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

Buy This Drugmaker Stock Because Its Turnaround Could Be Accelerated

·5 min read
Buy This Drugmaker Stock Because Its Turnaround Could Be Accelerated
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The long-awaited turnaround for British drugmaker GlaxoSmithKline could soon be at hand, with some nudging from activist hedge fund Elliott Management.